Home / Research and experimental development on biotechnology (except medical and veterinary science)

FLUXO TECHNOLOGIES PTE. LTD.

Live CompanyUEN 202511048ZLocal Company

FLUXO TECHNOLOGIES PTE. LTD. is a local company in Singapore with UEN 202511048Z. It was registered on 13 Mar 2025, 1 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202511048Z
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered13 Mar 2025
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity46900 Wholesale trade of a variety of goods without a dominant product
Address140 UPPER BUKIT TIMAH ROAD, #03-10, BEAUTY WORLD PLAZA, Singapore 588176
229 companies at this address
AreaBukit Timah · District 21 (Upper Bukit Timah, Clementi Park, Ulu Pandan)
Nearest stationBeauty World MRT, about 33 m
Officers2

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.